These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5100061)

  • 1. Growth hormone in uremia. I. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uremic subjects.
    Orskov H; Christensen NJ
    Scand J Clin Lab Invest; 1971 Feb; 27(1):51-60. PubMed ID: 5100061
    [No Abstract]   [Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
    Gossain VV; Sherma NK; Michelakis AM; Rovner DR
    Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azotemia and glucose intolerance.
    Cerletty JM; Engbring NH
    Ann Intern Med; 1967 Jun; 66(6):1097-108. PubMed ID: 6027945
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
    Vlachoyannis J; Schoeppe W
    Klin Wochenschr; 1982 Jul; 60(13):651-7. PubMed ID: 6289001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunologic analysis of insulin (IRI) in glucose metabolism in uremic patients].
    Martino F; Baviera G; Bonanno N; Purello D'Ambrosio F
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):329-39. PubMed ID: 2701029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of electroanesthesia. 8. Blood chemical changes during electroanesthesia].
    Higashi H; Shimoji T; Terasaki H; Kano T; Morioka T
    Masui; 1971 Jun; 20(6):477-81. PubMed ID: 5105522
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acutely infused pentagastrin and somatostatin on intestinal calcium absorption in humans.
    Scholz D; Schwille PO
    Miner Electrolyte Metab; 1982 Feb; 7(2):76-85. PubMed ID: 6133213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
    Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE
    Metabolism; 1988 Jul; 37(7):640-4. PubMed ID: 3290622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
    Ferrannini E; Pilo A; Tuoni M
    Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of glucose intolerance in uremia.
    DeFronzo RA
    Metabolism; 1978 Dec; 27(12 Suppl 2):1866-80. PubMed ID: 723638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-induced insulin secretion in uremia: relation with acid-base balance and effects of bicarbonate administration.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Nephron; 1993; 63(1):43-8. PubMed ID: 8446250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.